Antibodies Stocks List

Symbol Grade Name % Change
ACOR D Acorda Therapeutics, Inc. 3.09
AVEO B AVEO Pharmaceuticals, Inc. 0.23
CBPO A China Biologic Products, Inc. 0.02
CEMI F Chembio Diagnostics, Inc. 10.40
CGEN F Compugen Ltd. -1.43
HALO B Halozyme Therapeutics, Inc. 8.98
MACK D Merrimack Pharmaceuticals, Inc. 1.81
PRTA B Prothena Corporation plc 8.72
REGN F Regeneron Pharmaceuticals, Inc. -2.01
TECH C Techne Corporation -0.58
TRIB C Trinity Biotech plc -1.28
VIVO D Meridian Bioscience Inc. 4.10
XOMA F XOMA Corporation 3.40
AZN F Astrazeneca PLC 1.60
BDX F Becton, Dickinson and Company -0.40
ENZ D Enzo Biochem, Inc. 1.99
MGNX F MacroGenics, Inc. 3.84
XNCR C Xencor, Inc. 0.31
AKER D Akers Biosciences Inc 15.36
ATNM F Actinium Pharmaceuticals, Inc. -0.25
QTNT F Quotient Limited -5.69
CFRX D ContraFect Corporation 5.64
ADMA D ADMA Biologics Inc 0.40
GMAB F Genmab A/S -4.28
XBIT C XBiotech Inc. 0.00
FSTX D F-star Therapeutics, Inc. -1.16
MRUS D Merus N.V. -4.81
OTLK D Outlook Therapeutics, Inc. 8.02
SELB D Selecta Biosciences, Inc. -1.08
ANAB D AnaptysBio, Inc. -0.82
CKPT D Checkpoint Therapeutics, Inc. 1.49
IFRX D InflaRx N.V. 0.38
ACET C Adicet Bio, Inc. 4.39
MOR F MorphoSys AG -0.19
ALLK F Allakos Inc. 1.24
VCNX D Vaccinex, Inc. 5.76
ARDS F Aridis Pharmaceuticals Inc. -4.75
STRO F Sutro Biopharma, Inc. 5.64
DYAI F Dyadic International, Inc. -1.04
BCEL C Atreca, Inc. 5.57
IMVT F Immunovant, Inc. -1.02
IGMS D IGM Biosciences, Inc. -0.89
IPHA F Innate Pharma S.A. -2.69
CABA F Cabaletta Bio, Inc. 3.70
FUSN F Fusion Pharmaceuticals Inc. 0.77
IMNM C Immunome, Inc. 51.67
ABCM C Abcam plc -3.52
ABCL F AbCellera Biologics Inc. 3.27
FDMT D 4D Molecular Therapeutics, Inc. 4.44
IPA F ImmunoPrecise Antibodies Ltd. -0.71
CGEM F Cullinan Management, Inc. -0.50
ADAG F Adagene Inc. 0.56
View As Page of Charts


Recent Signals

Date Stock Signal Type
2021-02-24 ABCL Stochastic Buy Signal Bullish
2021-02-24 ABCL NR7 Range Contraction
2021-02-24 ABCL Narrow Range Bar Range Contraction
2021-02-24 ABCL Slingshot Bearish Bearish Swing Setup
2021-02-24 ABCM Fell Below 20 DMA Bearish
2021-02-24 ABCM Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-02-24 ACOR Lower Bollinger Band Walk Weakness
2021-02-24 ADAG NR7 Range Contraction
2021-02-24 ADAG Hot IPO Pullback Bullish Swing Setup
2021-02-24 ADAG Doji - Bullish? Reversal
2021-02-24 ADAG NR7-2 Range Contraction
2021-02-24 ADMA 200 DMA Resistance Bearish
2021-02-24 AKER Crossed Above 20 DMA Bullish
2021-02-24 AKER Calm After Storm Range Contraction
2021-02-24 AKER Crossed Above 200 DMA Bullish
2021-02-24 ALLK NR7 Range Contraction
2021-02-24 ALLK Slingshot Bearish Bearish Swing Setup
2021-02-24 ANAB Stochastic Reached Oversold Weakness
2021-02-24 ATNM Stochastic Reached Oversold Weakness
2021-02-24 AVEO 20 DMA Support Bullish
2021-02-24 BDX Cup with Handle Other
2021-02-24 BDX Fell Below 200 DMA Bearish
2021-02-24 BDX Lower Bollinger Band Walk Weakness
2021-02-24 CABA Pocket Pivot Bullish Swing Setup
2021-02-24 CABA Crossed Above 200 DMA Bullish
2021-02-24 CABA NR7 Range Contraction
2021-02-24 CABA Slingshot Bearish Bearish Swing Setup
2021-02-24 CEMI Lower Bollinger Band Walk Weakness
2021-02-24 CEMI 200 DMA Resistance Bearish
2021-02-24 CEMI Bullish Engulfing Bullish
2021-02-24 CFRX Crossed Above 20 DMA Bullish
2021-02-24 CFRX Crossed Above 200 DMA Bullish
2021-02-24 CGEM 1,2,3 Pullback Bullish Bullish Swing Setup
2021-02-24 CGEM Boomer Buy Setup Bullish Swing Setup
2021-02-24 CGEN Lower Bollinger Band Walk Weakness
2021-02-24 CGEN Stochastic Reached Oversold Weakness
2021-02-24 CKPT 20 DMA Resistance Bearish
2021-02-24 DYAI 50 DMA Resistance Bearish
2021-02-24 DYAI Stochastic Reached Oversold Weakness
2021-02-24 ENZ Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-02-24 FSTX 50 DMA Resistance Bearish
2021-02-24 FSTX NR7 Range Contraction
2021-02-24 FUSN 20 DMA Resistance Bearish
2021-02-24 FUSN Bullish Engulfing Bullish
2021-02-24 GMAB Fell Below 200 DMA Bearish
2021-02-24 GMAB Volume Surge Other
2021-02-24 GMAB Lower Bollinger Band Walk Weakness
2021-02-24 GMAB Calm After Storm Range Contraction
2021-02-24 HALO Wide Range Bar Range Expansion
2021-02-24 HALO New 52 Week High Strength
2021-02-24 HALO Pocket Pivot Bullish Swing Setup
2021-02-24 HALO New Uptrend Bullish
2021-02-24 HALO New 52 Week Closing High Bullish
2021-02-24 HALO Crossed Above 20 DMA Bullish
2021-02-24 HALO Expansion Breakout Bullish Swing Setup
2021-02-24 HALO Expansion Pivot Buy Setup Bullish Swing Setup
2021-02-24 HALO Volume Surge Other
2021-02-24 IFRX Stochastic Reached Oversold Weakness
2021-02-24 IGMS 50 DMA Support Bullish
2021-02-24 IGMS Spinning Top Other
2021-02-24 IMNM Parabolic Rise Strength
2021-02-24 IMNM Volume Surge Other
2021-02-24 IMNM Wide Range Bar Range Expansion
2021-02-24 IMNM New 52 Week Closing High Bullish
2021-02-24 IMNM Upper Bollinger Band Walk Strength
2021-02-24 IMVT Narrow Range Bar Range Contraction
2021-02-24 IMVT Calm After Storm Range Contraction
2021-02-24 IPA Calm After Storm Range Contraction
2021-02-24 IPHA Fell Below 20 DMA Bearish
2021-02-24 IPHA Fell Below 50 DMA Bearish
2021-02-24 IPHA MACD Bearish Signal Line Cross Bearish
2021-02-24 MACK 1,2,3 Pullback Bullish Bullish Swing Setup
2021-02-24 MACK 50 DMA Resistance Bearish
2021-02-24 MACK NR7 Range Contraction
2021-02-24 MGNX Crossed Above 20 DMA Bullish
2021-02-24 MGNX Slingshot Bearish Bearish Swing Setup
2021-02-24 MOR Lower Bollinger Band Walk Weakness
2021-02-24 MRUS Lower Bollinger Band Walk Weakness
2021-02-24 MRUS Fell Below 50 DMA Bearish
2021-02-24 PRTA 180 Bullish Setup Bullish Swing Setup
2021-02-24 QTNT MACD Bearish Signal Line Cross Bearish
2021-02-24 REGN Slingshot Bearish Bearish Swing Setup
2021-02-24 REGN 180 Bearish Setup Bearish Swing Setup
2021-02-24 SELB NR7 Range Contraction
2021-02-24 SELB 1,2,3 Pullback Bullish Bullish Swing Setup
2021-02-24 SELB Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-02-24 SELB Stochastic Reached Oversold Weakness
2021-02-24 STRO Bullish Engulfing Bullish
2021-02-24 TECH Fell Below 20 DMA Bearish
2021-02-24 TECH Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-02-24 TECH 1,2,3 Pullback Bullish Bullish Swing Setup
2021-02-24 TRIB 20 DMA Resistance Bearish
2021-02-24 VCNX Calm After Storm Range Contraction
2021-02-24 VIVO Calm After Storm Range Contraction
2021-02-24 XBIT Doji - Bullish? Reversal
2021-02-24 XBIT Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-02-24 XBIT Stochastic Reached Oversold Weakness
2021-02-24 XNCR Pocket Pivot Bullish Swing Setup
2021-02-24 XNCR Stochastic Reached Oversold Weakness
2021-02-24 XNCR Wide Range Bar Range Expansion
2021-02-24 XNCR 50 DMA Support Bullish
2021-02-24 XNCR 20 DMA Resistance Bearish
2021-02-24 XOMA NR7 Range Contraction
2021-02-24 XOMA Bullish Engulfing Bullish

Recent News for Antibodies Stocks

Date Stock Title
Feb 25 TECH Bitcoin Uses More Electricity Than Any Method Known To Mankind, Says Bill Gates
Feb 25 AZN UPDATE 1-AstraZeneca says it will have no vaccine supply shortfall in Q2, EU wary
Feb 25 TECH Nvidia Raked In $100-300M From Ethereum Miners In Q4 Amid GPU Supply Crunch
Feb 25 XNCR Xencor and UCLA Enter Collaboration to Discover and Develop Novel XmAb® Therapeutics
Feb 25 TECH Facebook, Google To Share Revenue With Australian Media As Country Passes Law With Global Implications
Feb 25 TECH Verizon Emerges As Top Bidder In $81B 5G Spectrum Auction
Feb 25 TECH GM Joint Venture's $4500 EV Outsold Tesla Model 3 In China: Report
Feb 25 IMVT IMVT INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Immunovant, Inc.
Feb 25 AZN S.Korea preps coronavirus vaccines after political scuffle over first shots
Feb 25 HALO Halozyme Therapeutics, Inc. Announces Pricing of Private Offering of $700 Million of Convertible Senior Notes due 2027
Feb 24 TECH 6 Key Questions Apple Answered At The Annual Shareholder Event
Feb 24 AZN Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bit Digital, CleanSpark, 9F, Inc., and AstraZeneca and Encourages Investors to Contact the Firm
Feb 24 TECH Snapchat's 'Open-Ended Growth Story' Solidified After Analyst Day Event
Feb 24 TECH Exclusive: REE Automotive CEO Daniel Barel On What Makes EV Platform Unique
Feb 24 AZN Bulgaria accuses AstraZeneca of taking country's vaccine "hope" away
Feb 24 SELB Selecta Biosciences' ImmTOR nanoparticles shows promise in gene therapy study
Feb 24 SELB Selecta Biosciences Announces Science Advances Publication Highlighting Potential Potency and Durability Benefits of ImmTOR™ in Gene Therapy
Feb 24 IFRX InflaRx launches stock offering
Feb 24 QTNT Quotient Limited to Participate in the Cowen 41st Annual Healthcare Conference
Feb 24 PRTA Prothena Announces Promising New Preclinical and Clinical Data from its Neurodegenerative Programs Selected for Oral Presentations at AD/PD 2021

An antibody (Ab), also known as an immunoglobulin (Ig), is a large, Y-shaped protein produced mainly by plasma cells that is used by the immune system to neutralize pathogens such as pathogenic bacteria and viruses. The antibody recognizes a unique molecule of the pathogen, called an antigen, via the Fab's variable region. Each tip of the "Y" of an antibody contains a paratope (analogous to a lock) that is specific for one particular epitope (similarly, analogous to a key) on an antigen, allowing these two structures to bind together with precision. Using this binding mechanism, an antibody can tag a microbe or an infected cell for attack by other parts of the immune system, or can neutralize its target directly (for example, by inhibiting a part of a microbe that is essential for its invasion and survival). Depending on the antigen, the binding may impede the biological process causing the disease or may activate macrophages to destroy the foreign substance. The ability of an antibody to communicate with the other components of the immune system is mediated via its Fc region (located at the base of the "Y"), which contains a conserved glycosylation site involved in these interactions. The production of antibodies is the main function of the humoral immune system.Antibodies are secreted by B cells of the adaptive immune system, mostly by differentiated B cells called plasma cells. Antibodies can occur in two physical forms, a soluble form that is secreted from the cell to be free in the blood plasma, and a membrane-bound form that is attached to the surface of a B cell and is referred to as the B-cell receptor (BCR). The BCR is found only on the surface of B cells and facilitates the activation of these cells and their subsequent differentiation into either antibody factories called plasma cells or memory B cells that will survive in the body and remember that same antigen so the B cells can respond faster upon future exposure. In most cases, interaction of the B cell with a T helper cell is necessary to produce full activation of the B cell and, therefore, antibody generation following antigen binding. Soluble antibodies are released into the blood and tissue fluids, as well as many secretions to continue to survey for invading microorganisms.
Antibodies are glycoproteins belonging to the immunoglobulin superfamily. They constitute most of the gamma globulin fraction of the blood proteins. They are typically made of basic structural units—each with two large heavy chains and two small light chains. There are several different types of antibody heavy chains that define the five different types of crystallisable fragments (Fc) that may be attached to the antigen-binding fragments. The five different types of Fc regions allow antibodies to be grouped into five isotypes. Each Fc region of a particular antibody isotype is able to bind to its specific Fc Receptor (except for IgD, which is essentially the BCR), thus allowing the antigen-antibody complex to mediate different roles depending on which FcR it binds. The ability of an antibody to bind to its corresponding FcR is further modulated by the structure of the glycan(s) present at conserved sites within its Fc region. The ability of antibodies to bind to FcRs helps to direct the appropriate immune response for each different type of foreign object they encounter. For example, IgE is responsible for an allergic response consisting of mast cell degranulation and histamine release. IgE's Fab paratope binds to allergic antigen, for example house dust mite particles, while its Fc region binds to Fc receptor ε. The allergen-IgE-FcRε interaction mediates allergic signal transduction to induce conditions such as asthma.Though the general structure of all antibodies is very similar, a small region at the tip of the protein is extremely variable, allowing millions of antibodies with slightly different tip structures, or antigen-binding sites, to exist. This region is known as the hypervariable region. Each of these variants can bind to a different antigen. This enormous diversity of antibody paratopes on the antigen-binding fragments allows the immune system to recognize an equally wide variety of antigens. The large and diverse population of antibody paratope is generated by random recombination events of a set of gene segments that encode different antigen-binding sites (or paratopes), followed by random mutations in this area of the antibody gene, which create further diversity. This recombinational process that produces clonal antibody paratope diversity is called V(D)J or VJ recombination. Basically, the antibody paratope is polygenic, made up of three genes, V, D, and J. Each paratope locus is also polymorphic, such that during antibody production, one allele of V, one of D, and one of J is chosen. These gene segments are then joined together using random genetic recombination to produce the paratope. The regions where the genes are randomly recombined together is the hyper variable region used to recognise different antigens on a clonal basis.
Antibody genes also re-organize in a process called class switching that changes the one type of heavy chain Fc fragment to another, creating a different isotype of the antibody that retains the antigen-specific variable region. This allows a single antibody to be used by different types of Fc receptors, expressed on different parts of the immune system.

More about Antibodies
Browse All Tags